Announcements Trials
Browse Landscape

Phase

Phase 2 54Phase 3 47Phase 1 12Phase 4 6Phase 1/2 6Phase NA 5Phase 2/3 3Phase EARLY_PHASE1 1

Status

Terminated 2Completed 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 6

Conditions

Prostatic Neoplasms 6Breast Neoplasms 2Primary Dysautonomias 1Patients With T1-4 Advanced Prostate Cancer 1Neoplasms 1Myofibroma 1Leiomyoma 1Kidney Diseases 1Hypertension 1Advanced Prostate Cancer 1

Interventions

Zoledronic Acid 14Leuprolide 9bicalutamide 6Triptorelin Pamoate 6Goserelin 6luprolide acetate gel depot 5enzalutamide 5acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 5Dutasteride 5fluciclovine F-18 3darolutamide 3Sodium Chloride 3Prednisone 3Magnetic Resonance Spectroscopy 3Flutamide 3Androgen Antagonists 3Abiraterone Acetate 32-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3cabazitaxel 2Propofol 2Prednisolone 2Lidocaine 2Gonadotropin-Releasing Hormone 2Finasteride 2Dexamethasone 2Desflurane 2Ciprofloxacin 2testosterone 17 beta-cypionate 1semaglutide 1polyethylene glycol 3350 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 4 × Prostatic Neoplasms × Goserelin × Clear all
NCT05700903 2026-03-02

ARCH

University of Colorado, Denver

Phase 4 Completed
10 enrolled
Genitourinary

Hypertension, Kidney Diseases, Prostatic Neoplasms, Primary Dysautonomias

NCT01673984 2025-05-23

GREAT

Ipsen

Phase 4 Terminated
27 enrolled 13 charts
Genitourinary

Prostatic Neoplasms

NCT04248621 2021-07-29

Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients

Wonju Severance Christian Hospital

Phase 4 Unknown
164 enrolled
Genitourinary

Prostatic Neoplasms

NCT02749825 2016-04-25

Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer

Pharmatech

Phase 4 Terminated
41 enrolled
Genitourinary

Neoplasms, Prostatic Neoplasms

NCT00255268 2007-08-28

CMAB vs IMAB in Metastatic Prostate Cancer

AstraZeneca

Phase 4 Withdrawn
15 enrolled
Genitourinary

Prostatic Neoplasms

NCT00293696 2007-05-08

Casodex/Zoladex Biomarkers in Localised Prostate Cancer

Tampere University

Phase 4 Completed
30 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡